Replacement Warrant to Narkis Gryp Ltd

Your Internet Defender, Inc. 8-K/A

Exhibit 10.24

Warrant

To: NARKIS GRYP Ltd. (the “Holder”)

Date: August 12, 2014

WARRANT

to Purchase Common Stock

(“Common Stock”)

of Corindus Vascular Robotics, Inc.

Subject to the terms and conditions set forth below

VOID AFTER 24:00 p.m. Eastern Time

On the last day of the Warrant Period (defined below).

(issued in replacement of the Warrant issued October 11, 2010)

WHEREAS, Corindus, Inc., (the “Predecessor Company”) issued to the Holder that certain Warrant to Purchase Series A Preferred Stock, dated October 11, 2010 (the “Prior Warrant”);

WHEREAS, the Predecessor Company and Corindus Vascular Robotics, Inc. (the “Company”) entered into a Securities Exchange and Acquisition Agreement dated August 5, 2014 whereby the Company agreed to acquire 100% of the issued and outstanding shares of common stock and preferred stock of the Predecessor Company and rights to acquire shares of common stock and preferred stock of the Predecessor Company, including the Prior Warrant, through an acquisition in exchange for the issuance of shares and rights to acquire shares of the Company’s Common Stock; and

WHEREAS, the Company and the Holder desire to amend and restate the Prior Warrant as set forth in this Warrant to reflect the right to purchase shares of Common Stock of the Company.

NOW, THEREFORE, the parties hereby agree as follows:

This is to certify that the Holder is entitled to purchase, subject to the provisions of this Warrant, from the Company, at any time from the date hereof, and terminating upon May 31, 2017 (the “Warrant Period”), up to 124,160 fully paid and non-assessable shares of Common Stock, par value of $0.0001 per share (the “Warrant Shares” or “Shares”) of the Company at an exercise price of USD$0.7648 per Warrant Share, all subject to adjustments for anti-dilution, sub-division, split, combination or recapitalization, pursuant to the Certificate of Incorporation of the Company, as amended from time to time (the “Exercise Price”, and “Certificate”, respectively). This Warrant is issued in substitution of and replacement for the Prior Warrant.

The term “IPO” means an initial public offering of the shares of the Company.

The term “Sale” means the sale of all or substantially all of the assets of the Company.

The term “Merger” means a merger in which the shareholders of the Company, immediately after the merger, do not own a majority of the outstanding shares of the surviving corporation.

The term “Distribution” means distribution of cash dividend.

wherein –

X equals the number of shares of Common Stock to be issued to the Holder;

Y equals the number of shares of Common Stock obtainable upon conversion of the Warrant Shares to which the Holder is entitled upon exercise of this Warrant (as adjusted to the date of such calculation, but excluding those shares already issued under this Warrant);

B equals the Exercise Price in effect at the time of exercise pursuant to this formula; and

A equals the fair market value of one share of Common Stock of the Company.

Fair market value shall be determined as follows:

With reference to the exercise of this Warrant, in whole or in part, in connection with the IPO, fair market value shall mean the price to the public in the IPO of one share of Common Stock, less the underwriter’s commission;

With reference to the exercise of this Warrant, in whole or in part, in connection with a Sale or a Merger, the fair market value of a share of Common Stock shall be as calculated by the auditors of the Company, based on the total consideration to be received by the Company (for its stock or assets, as the case may be), taking into account the number of shares calculated on a fully diluted basis (including the Warrant Shares to be issued pursuant to this Warrant), and taking into account the rights attached to the Warrant Shares pursuant to the Certificate.

If the Common Stock of the Company is traded on a securities exchange or through the Nasdaq National Market, the fair market value shall be deemed to be the average of the closing prices of the securities on such quotation system over the thirty (30) day period ending three (3) days prior to the date of the exercise notice.

If there is no active public market, the fair market value shall be as determined by an independent public accountant retained by the Holder in consultation with the Board of Directors of the Company.

No fractions of Shares shall be issued in connection with the exercise of this Warrant, and the number of Shares issued shall be rounded down to the nearest whole number.

The Company hereby agrees that at all times it will maintain and reserve, free from preemptive rights, such number of authorized but unissued Warrant Shares so that this Warrant may be exercised without additional authorization of Warrant Shares after giving effect to all other options, warrants, convertible securities and other rights to acquire shares of the Company. The Company further agrees that it will not, by amendment of its Certificate or through reorganization, consolidation, merger, dissolution or sale of assets, or by any other voluntary act, avoid or seek to avoid the observance or performance of any of the covenants, stipulations or conditions to be observed or performed buyer by the Company, or the provisions contained in the Certificate relating to the rights of the holders of the Warrant Shares.

The number of Shares purchasable upon the exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time or upon exercise as provided in this Section 3 if any of the mentioned below occurs prior to the end of the Warrant Period:

Upon the occurrence of any transaction referred to in Section 5 of the Amended and Restated Voting Agreement dated November 18, 2009 between the Predecessor Company and the various entities party thereto (the “Voting Agreement”), the Board of Directors of the Company may issue to the Holder hereof a 30 day written notice under which the Warrant shall expire if not exercised immediately prior to the closing of such transaction and subject to the consummation of said transaction. To avoid any doubt, shares acquired as a result of the exercise of the Warrant shall become part of the Sale of the Company (as defined in the Voting Agreement).

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or destruction) of reasonably satisfactory indemnification, and upon surrender and cancellation of this Warrant, if mutilated, the Company will execute and deliver a new Warrant of like tenor and date. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether or not the Warrant so lost, stolen, destroyed or mutilated, shall be at any time enforceable by anyone.

The Company undertakes not to enter into any share swap agreement or arrangement (such as a merger, reorganization, or sale of all, or substantially all, of the Company’s shares) (“Share Swap”), unless the other Company to such a Share Swap agreement undertakes to allot to the Holder, upon, and subject to, the exercise of this Warrant, such securities as were swapped for the shares of the Company, as though the Holder had held the Warrant Shares on the record date of the Share Swap.

The Company represents and warrants to the Holder as follows:

This Warrant and the rights conferred hereby shall terminate at the aforementioned time on the last day of the Warrant Period.

This Warrant shall be governed by, and interpreted in accordance with, the laws of the State of Delaware, without giving effect to the rules respecting conflict of law.

Unless otherwise provided, any notice required or permitted under this Warrant shall be given in writing, with a duplicate copy sent via email and shall be deemed effectively given upon personal delivery to the party to be notified or 7 (seven) days after deposit with a Post Office, for dispatch by registered or certified mail, postage prepaid and addressed to the Holder at the address set forth in the Company’s books and to the Company at the address of its principal offices. With respect to Holders located outside Israel, such notice shall be deemed effectively given upon personal delivery to the party to be notified, 10 (ten) business days after deposit with a Post Office for dispatch by registered or certified airmail, or when given by telex, telecopier, facsimile or other form of rapid written communication, the day sent, provided that confirming copies are sent by such airmail.

This Warrant amends and restates in its entirety the Prior Warrant. Any term of this Warrant may only be amended with the written consent of (i) the Company and (ii) the Holder.

8